Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 3, 2005, Pages 590-595

  Jemal, Ahmedin ^a   Ward, Elizabeth ^a   Wu, Xiaocheng ^b   Martin, Howard J ^c   McLaughlin, Colleen C ^d   Thun, Michael J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b LOUISIANA STATE UNIV HLTH SCI C   (United States)

^c Virginia Cancer Institute   (United States)

^d New York State Cancer Registry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CORRELATION ANALYSIS; DATA ANALYSIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RURAL AREA; UNITED STATES; UTILIZATION REVIEW;

ADULT; AGED; GEOGRAPHY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; PROSTATIC NEOPLASMS; REGISTRIES; UNITED STATES;

EID: 17044367075     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0522     Document Type: Article

References (37)

1. Devesa S, Grauman D, Blot W, Pennello G, Hoover RN, Fraumeni JF Jr. Atlas of cancer mortality in the United States, 1950-94. Vol. 99-4564: NIH; Washington (DC): U.S. Government Printing Office; 1999.
2. Blair A, Fraumeni JF. Geographic patterns of prostate cancer in the United States. J Natl Cancer Inst 1978;61:1379-84.
3. Dosemeci M, Hoover RN, Blair A, et al. Farming and prostate cancer among African-Americans in the southeastern United States. J Natl Cancer Inst 1994;86:1718-9.
4. Jemal A, Kulldorff M, Devesa SS, Hayes RB, Fraumeni JF Jr. A geographic analysis of prostate cancer mortality in the United States, 1970-89. Int J Cancer 2002;101:168-74.
5. Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer. Part II. Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 1999;91:1025-32.
6. Ries LAG, Eisner M, Kosary C, et al. SEER Cancer Statistics Review, 1975-2000, National Cancer Institute. Bethesda (MD), http://seer.cancer.gov/csr/ 1975_2000; 2003.
7. Holes J, Wu XC, McLaughlin C, et al. Cancer in North America, 1996-2000. Volume Three: NAACCR Combined Incidence Rates. Springfield (IL): North American Association of Cancer Registries; 2003.
8. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, editors. SEER summary staging manual, 2000: codes and coding instructions; NIH Pub. No. 01-4969. Bethesda (MD): National Cancer Institute; 2001.
9. Shambaugh EM, Weiss MA, Axtell LM, Ryan RF, Platz CE. Summary staging guide for the cancer surveillance, epidemiology, and end results reporting (SEER) program. Bethesda (MD): NIH; 1983.
10. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003;95:1276-99.
11. USDA. Measuring rurality: rural-urban continuum codes: Economic Research Service: US Department of Agriculture, http://ers.usda.gov/Briefing/Rurality/ ruralurban/; Accessed August 2004.
12. Fleiss JL, Livin B, Cho Paik M. Statistical methods for rates and proportions. Hoboken (NJ): John Wiley & Sons, Inc; 2003. p. 760.
13. SAS Institute, Inc. SAS/STAT user's guide, version 6. Vol. 1. Cary: SAS Institute, Inc; 1989. p. 943.
14. Parker AS, Cerhan JR, Putnam SD, Cantor KP, Lynch CF. A cohort study of farming and risk of prostate cancer in Iowa. Epidemiology 1999;10:452-5.
15. Acquavella J, Olsen G, Cole P, et al. Cancer among farmers: a meta-analysis. Ann Epidemiol 1998;8:64-74.
16. Blair A, Zahm SH. Cancer among farmers. Occup Med 1991;6:335-54.
17. Blair A, Zahm SH. Agricultural exposures and cancer. Environ Health Perspect 1995;103 Suppl 8:205-8.
18. Keller-Byrne JE, Khuder SA, Schaub EA. Meta-analyses of prostate cancer and farming. Am J Ind Med 1997;31:580-6.
19. Parent ME, Siemiatycki J. Occupation and prostate cancer. Epidemiol Rev 2001;23:138-43.
20. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
21. Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 2001;10:345-53.
22. Andersson SO, Wolk A, Bergstrom R, et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997;89:385-9.
23. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990;10:1307-11.
24. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992;70:2861-9.
25. Braun MM, Helzlsouer KJ, Hollis BW, Comstock CW. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 1995;6:235-9.
26. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000;11:847-52.
27. Corder EH, Guess HA, Hulka BS, et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 1993;2:467-72.
28. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 1996;5:121-6.
29. Nomura AM, Stemmermann GN, Lee J, et al. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control 1998;9:425-32.
30. Rodriguez C, McCullough ML, Mondul AM, et al. Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men. Cancer Epidemiol Biomarkers Prev 2003;12:597-603.
31. Roche LM, Skinner R, Weinstein RB. Use of a geographic information system to identify and characterize areas with high proportions of distant stage breast cancer. J Public Health Manag Pract 2002;8:26-32.
32. Polednak AP. Later-stage cancer in relation to medically underserved areas in Connecticut. J Health Care Poor Underserved 2000;11:301-9.
33. Liff JM, Chow WH, Greenberg RS. Rural-urban differences in stage at diagnosis. Possible relationship to cancer screening. Cancer 1991;67:1454-9.
34. Surveillance Epidemiology and End Results (SEER) Program. SEER 1975-2000 public use data. SEER*Stat Database: Incidence-SEER 9 Regs, Nov 2002 Sub (1973-2001) 〈18 Age Groups〉. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the 2002 submission.
35. Nelson DE, Bland S, Powell-Griner E, et al. State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s. JAMA 2002;287:2659-67.
36. Jordan TR, Price JH, King KA, Masyk T, Bedell AW. The validity of male patients' self-reports regarding prostate cancer screening. Prev Med 1999;28:297-303.
37. Volk RJ, Cass AR. The accuracy of primary care patients' self-reports of prostate-specific antigen testing. Am J Prev Med 2002;22:56-8.